| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/18/2004 | EP1446149A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides |
| 08/18/2004 | EP1446148A1 Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid |
| 08/18/2004 | EP1446147A1 Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446145A1 Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides |
| 08/18/2004 | EP1446144A2 The use of leptin in infertility |
| 08/18/2004 | EP1446143A2 Use of obg3 for promoting central nervous system remyelination |
| 08/18/2004 | EP1446142A1 Potentiating the therapeutic effects of interferons |
| 08/18/2004 | EP1446141A2 Regulation of mononuclear phagocyte stimulation |
| 08/18/2004 | EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446139A2 Pharmaceutical composition containing sfcyr iib or sfcyr iii |
| 08/18/2004 | EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446137A2 Somatostatin analog and uses thereof |
| 08/18/2004 | EP1446133A2 Methods of improving central nervous system functioning |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446122A1 Use of flibanserin in the treatment of sexual disorders |
| 08/18/2004 | EP1446114A1 Compositions and methods for treating osteoporosis |
| 08/18/2004 | EP1446101A2 Catheter injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446099A1 Injectable depot composition |
| 08/18/2004 | EP1446096A1 Topical compositions containing enzymes stabilised with inhibitors |
| 08/18/2004 | EP1446022A1 Oilseed processing |
| 08/18/2004 | EP1446014A2 INTRODUCTION OF THE WLDs GENE FOR PREVENTION OF AXONAL DEGENERATION IN NEUROLOGICAL DISEASES |
| 08/18/2004 | EP1446013A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/18/2004 | EP1446012A1 Combination bacteriolytic therapy for the treatment of tumors |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1395273A4 Targeted delivery of drugs for the treatment of viral infections |
| 08/18/2004 | EP1345585A4 Compositions for prevention and alleviation of skin wrinkles |
| 08/18/2004 | EP1325026B1 Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
| 08/18/2004 | EP1315739B1 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 08/18/2004 | EP1179020A4 Low-dose il-1beta-induced photoreceptor cell rescue without retinal dysplasia |
| 08/18/2004 | EP1140837B1 Compounds useful in the treatment of inflammatory diseases |
| 08/18/2004 | EP1087935B1 Anthracene derivatives as anti-cancer agents |
| 08/18/2004 | EP1079803B1 Protein formulations |
| 08/18/2004 | EP1073671A4 Targeted gene delivery to cells by filamentous bacteriophage |
| 08/18/2004 | EP1038025A4 Genetic alterations associated with cancer |
| 08/18/2004 | EP1012188B1 Composition for treating diabetes mellitus and obesity |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0970118B1 Specific pancreatic lipase inhibitors and their applications |
| 08/18/2004 | EP0954330A4 Intestinal trefoil proteins |
| 08/18/2004 | EP0881914B1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/18/2004 | EP0877622B1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/18/2004 | EP0876166B1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
| 08/18/2004 | EP0871730B1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 08/18/2004 | EP0871474A4 Generation of human insulin |
| 08/18/2004 | EP0862622B1 Method of screening for RAC protein kinase interacting compounds |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0775160B1 Cyclic hexapeptide somatostatin analogues |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522300A Novel maxizyme |
| 08/18/2004 | CN1522299A Coagulation factor vii derivatives |
| 08/18/2004 | CN1522159A Interferon formulations |
| 08/18/2004 | CN1522156A Novel engineered superantigen for human therapy |
| 08/18/2004 | CN1522154A Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 08/18/2004 | CN1522151A Modified fvii in treatment of ards |
| 08/18/2004 | CN1522139A Enhanced parmacokinetic profile of hydrophobic substances |
| 08/18/2004 | CN1521257A Microencapsulated cell of human tissue kallikrein, microencapsulating method and application thereof |
| 08/18/2004 | CN1521192A Human erythropoietin Fc fusion protein with high bioactivity |
| 08/18/2004 | CN1521191A Recombinant protein molecule for inhibiting attack and transfer of cancer cell and angiogenesis |
| 08/18/2004 | CN1521189A Analogs of parathyroid hormone |
| 08/18/2004 | CN1521188A Protein extracted from perinereis aibuhitensis, its preparation method and use |
| 08/18/2004 | CN1520895A Sustained delivery of an active agent using an implantable system |
| 08/18/2004 | CN1520882A Trombolysis agent KGD - prourokinase chimaera, preparing process and application thereof |
| 08/18/2004 | CN1520881A Sterilizing preparation for preventing and curing bovine mastitis and preparing process thereof |
| 08/18/2004 | CN1520880A Hemostatic |
| 08/18/2004 | CN1520838A Bitter gourd extract plant insulin ; novel use of bitter gourd saponin |
| 08/18/2004 | CN1520829A Earthworm freeze dried powder injection and preparation method |
| 08/18/2004 | CN1520827A Amino acid loaded trityl alcohol resins, method of producing same and use thereof |
| 08/18/2004 | CN1162543C Gene encoding sulfotransferase |
| 08/18/2004 | CN1162446C Insulinotropic hormone secretion peptide derivative |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777539 Cytokine antagonists; detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; immunostimulants |
| 08/17/2004 | US6777538 Binding protein |
| 08/17/2004 | US6777536 EPH receptor ligands, and uses related thereto |
| 08/17/2004 | US6777535 Useful for treating conditions which arise or are exacerbated by angiogenesis |
| 08/17/2004 | US6777534 Use of those antagonists in the treatment of disorders that are associated with vascular endothelial growth factor (vegf) |
| 08/17/2004 | US6777443 For therapy of cardiovascular disorders in mammals; for inhibiting both angiotensin converting enzyme and neutral endopeptidase in mammals |
| 08/17/2004 | US6777439 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 08/17/2004 | US6777403 Method and structure for inhibiting activity of serine elastases |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6777390 Stable blood coagulation inhibitor-free factor vii preparation and method for preparing same |
| 08/17/2004 | US6777388 Correcting energy imbalance responsible for obese phenotype; utilizes amino acid sequences 2 and 18; homeostasis of body weight and adipose tissue mass |
| 08/17/2004 | US6777386 Peptide agonist or analogue other than deslorelin; lecithin and stearin; preferably comprises a gnrh agonist and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial |
| 08/17/2004 | US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex |
| 08/17/2004 | US6777232 Human membrane proteins and polynucleotides encoding the same |
| 08/17/2004 | US6777221 Can be used for diagnosis, drug screening, clinical trial monitoring and therapy of physiological disorders |
| 08/17/2004 | US6777217 Genes which are involved in the control of chromatin structure and, thus in transcription and translation; used to control cell proliferation and differentiation in vitro and in vivo |
| 08/17/2004 | US6777203 Telomerase promoter driving expression of therapeutic gene sequences |
| 08/17/2004 | US6777195 Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants |
| 08/17/2004 | US6777192 Contacting the sample with an isolated recombinant immunodominant neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex |
| 08/17/2004 | US6777191 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in diagnosis of viral infection |
| 08/17/2004 | US6777176 Target system |
| 08/17/2004 | US6777002 Process for microencapsulation of water soluble substances |
| 08/17/2004 | US6777000 Sustained release |
| 08/17/2004 | US6776992 Methods for treating tension headache |
| 08/17/2004 | US6776991 Treating painful penile erection; sexual disorders |